APLS RSI Chart
Last 7 days
-2.4%
Last 30 days
-19.5%
Last 90 days
-4.0%
Trailing 12 Months
-8.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 105.9M | 184.5M | 272.9M | 396.6M |
2022 | 80.9M | 96.6M | 113.0M | 75.4M |
2021 | 204.6M | 158.6M | 112.6M | 66.6M |
2020 | 6.5M | 6.1M | 128.4M | 250.6M |
2019 | 3.5M | 4.0M | 4.6M | 5.1M |
2018 | 1.6M | 0 | 0 | 3.0M |
2017 | 0 | 0 | 0 | 277.8K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 19, 2024 | dunlop a. sinclair | sold | -1,068,160 | 57.179 | -18,681 | - |
Mar 18, 2024 | delong mark jeffrey | sold | -564,050 | 56.9 | -9,913 | chief business & strat officer |
Mar 15, 2024 | chopas james george | sold | -10,388 | 56.461 | -184 | vp/chief accounting officer |
Mar 13, 2024 | nicholson nur | sold | -645,838 | 57.5613 | -11,220 | chief technical officer |
Mar 08, 2024 | deschatelets pascal | acquired | 253,623 | 3.67 | 69,107 | chief scientific officer |
Mar 08, 2024 | deschatelets pascal | sold | -4,297,550 | 62.1869 | -69,107 | chief scientific officer |
Mar 06, 2024 | watson david o. | acquired | 52,103 | 13.85 | 3,762 | general counsel |
Mar 01, 2024 | sullivan timothy eugene | acquired | 60,180 | 10.03 | 6,000 | chief financial officer |
Mar 01, 2024 | sullivan timothy eugene | sold | -379,340 | 63.2233 | -6,000 | chief financial officer |
Mar 01, 2024 | francois cedric | acquired | 1,050,000 | 4.2 | 250,000 | chief executive officer |
Which funds bought or sold APLS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | added | 0.04 | 2,615,420 | 7,170,330 | 0.01% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 0.9 | 211,765,000 | 572,003,000 | 0.01% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 87.21 | 24,561,600 | 37,183,000 | -% |
Feb 29, 2024 | Quintet Private Bank (Europe) S.A. | unchanged | - | 16,409 | 45,015 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -1.33 | 36,438 | 102,361 | -% |
Feb 26, 2024 | Virtu Financial LLC | sold off | -100 | -884,000 | - | -% |
Feb 22, 2024 | SIERRA SUMMIT ADVISORS LLC | new | - | 222,321 | 222,321 | 0.06% |
Feb 20, 2024 | EVENTIDE ASSET MANAGEMENT, LLC | new | - | 12,558,300 | 12,558,300 | 0.20% |
Feb 20, 2024 | Quarry LP | sold off | -100 | -133,140 | - | -% |
Feb 16, 2024 | HARBOUR INVESTMENTS, INC. | unchanged | - | 829 | 2,275 | -% |
Unveiling Apellis Pharmaceuticals Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Apellis Pharmaceuticals Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
Apellis Pharmaceuticals Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 32.6% | 146,377,000 | 110,399,000 | 94,969,000 | 44,846,000 | 22,663,000 | 22,056,000 | 16,322,000 | 14,381,000 | 60,290,000 | 5,650,000 | 623,000 | 723,500 | 824,000 | 924,500 | 1,025,000 | 2,275,000 | 1,478,779 | 1,342,000 | 1,421,000 | 867,000 | 633,701 |
Operating Expenses | -6.7% | 230,894,500 | 247,479,000 | 215,410,000 | 219,929,000 | 186,716,000 | 174,994,000 | 164,946,000 | 143,379,000 | 149,694,000 | 133,645,000 | 194,910,000 | 124,591,000 | 119,879,000 | 130,198,000 | 115,508,000 | - | - | 69,948,000 | - | - | - |
S&GA Expenses | -2.7% | 141,701,000 | 145,648,000 | 111,373,000 | 102,093,000 | 84,367,500 | 78,406,000 | 63,203,000 | 51,187,000 | 41,462,000 | 45,763,000 | 48,967,000 | 40,579,000 | 44,492,000 | 36,991,000 | 28,414,000 | 29,504,000 | 27,468,000 | 18,629,000 | 12,778,000 | 8,171,000 | 6,390,797 |
R&D Expenses | -12.8% | 69,281,500 | 79,421,000 | 95,658,000 | 110,027,000 | 99,423,000 | 95,207,000 | 101,661,000 | 90,945,000 | 78,181,000 | 87,733,000 | 95,943,000 | 84,012,000 | 50,337,500 | 93,207,000 | 87,094,000 | 69,282,000 | 78,472,000 | 51,319,000 | 50,698,000 | 40,480,000 | 30,806,035 |
EBITDA Margin | 40.4% | -1.31 | -2.21 | -3.54 | -6.48 | -8.55 | -5.53 | -6.50 | -8.55 | -11.03 | -2.94 | -2.05 | -1.59 | - | - | - | - | - | - | - | - | - |
Interest Expenses | -100.0% | - | 1,643,000 | - | 1,643,000 | - | 1,643,000 | - | 3,360,000 | - | 3,372,000 | - | 6,893,000 | - | 9,100,000 | - | 3,829,000 | 28,000 | 231,000 | 140,000 | 588,000 | 477,306 |
Income Taxes | 506.9% | 1,414,000 | 233,000 | 194,000 | 300,000 | -1,471,000 | 446,000 | 486,000 | 1,208,000 | 352,000 | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 37.7% | -87,153,000 | -140,004,000 | -121,843,000 | -177,496,000 | -167,462,000 | -190,823,000 | -155,491,000 | -137,727,000 | -147,581,000 | -195,571,000 | -219,191,000 | -183,659,000 | - | - | - | - | - | - | - | - | - |
EBT Margin | 40.3% | -1.33 | -2.22 | -3.56 | -6.53 | -8.64 | -5.59 | -6.58 | -8.65 | -11.21 | -3.05 | -2.16 | -1.68 | - | - | - | - | - | - | - | - | - |
Net Income | 36.8% | -88,576,000 | -140,237,000 | -122,037,000 | -177,778,000 | -165,991,000 | -191,269,000 | -155,977,000 | -138,935,000 | -147,933,000 | -195,571,000 | -219,191,000 | -183,659,000 | 78,265,000 | -135,700,000 | -118,617,000 | -168,822,000 | -113,218,000 | -69,825,000 | -71,090,000 | -50,574,000 | -36,459,475 |
Net Income Margin | 40.0% | -1.33 | -2.22 | -3.56 | -6.53 | -8.65 | -5.61 | -6.61 | -8.67 | -11.21 | -4.62 | -2.90 | -1.76 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 42.1% | -97,970,000 | -169,132,000 | -150,527,000 | -177,879,000 | -141,595,000 | -154,613,000 | -107,415,000 | -111,646,000 | -112,518,000 | -168,977,000 | -128,936,000 | -153,798,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -3.6% | 789 | 818 | 916 | 979 | 760 | 873 | 1,002 | 1,146 | 882 | 526 | 700 | 810 | 961 | 768 | 870 | 689 | 389 | 466 | 317 | 318 | 204 |
Current Assets | -3.8% | 766 | 797 | 893 | 954 | 720 | 832 | 960 | 1,104 | 824 | 475 | 655 | 774 | 917 | 742 | 854 | 672 | 373 | 451 | 308 | 311 | 202 |
Cash Equivalents | -22.4% | 351 | 452 | 616 | 765 | 552 | 584 | 604 | 633 | 640 | 284 | 271 | 265 | 567 | 416 | 317 | 418 | 352 | 434 | 289 | 288 | 176 |
Inventory | 48.5% | 146 | 99.00 | 103 | 85.00 | 86.00 | 60.00 | 48.00 | 33.00 | 16.00 | 2.00 | 4.00 | - | - | - | - | - | - | - | - | - | - |
Net PPE | -9.3% | 4.00 | 5.00 | 5.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 1.4% | 594 | 586 | 570 | 567 | 590 | 565 | 668 | 684 | 683 | 583 | 841 | 758 | 756 | 662 | 638 | 430 | 355 | 327 | 158 | 94.00 | 43.00 |
Current Liabilities | 33.4% | 248 | 186 | 175 | 139 | 168 | 115 | 127 | 125 | 132 | 94.00 | 158 | 84.00 | 128 | 75.00 | 58.00 | 51.00 | 66.00 | 45.00 | 36.00 | 20.00 | 17.00 |
Long Term Debt | 0.1% | 93.00 | 93.00 | 93.00 | 93.00 | 93.00 | 93.00 | 189 | 189 | 189 | 190 | 386 | 386 | 359 | 354 | 349 | 145 | 143 | - | - | - | - |
LT Debt, Non Current | 0.1% | 93.00 | 93.00 | 93.00 | 93.00 | 93.00 | 93.00 | 189 | 189 | 189 | 190 | 386 | 386 | 359 | 354 | 349 | 145 | 143 | - | - | - | - |
Shareholder's Equity | -16.3% | 195 | 232 | 345 | 412 | 170 | 307 | 334 | 462 | 199 | - | - | 52.00 | 205 | 106 | 232 | 259 | 34.00 | 140 | 159 | 225 | 161 |
Retained Earnings | -3.2% | -2,837 | -2,748 | -2,600 | -2,500 | -2,308 | -2,142 | -1,951 | -1,795 | -1,656 | -1,508 | -1,313 | -1,093 | -926 | -1,004 | -868 | -750 | -581 | -468 | -398 | -327 | -276 |
Additional Paid-In Capital | 1.8% | 3,036 | 2,982 | 2,955 | 2,900 | 2,480 | 2,453 | 2,289 | 2,260 | 1,857 | 1,453 | 1,174 | 1,147 | 1,131 | 1,112 | 1,101 | 1,008 | 616 | 608 | 558 | 552 | 438 |
Shares Outstanding | 1.0% | 120 | 118 | 118 | 116 | 111 | 110 | 107 | 106 | 84.00 | 87.00 | 81.00 | 79.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 10,700 | - | - | - | 4,800 | - | - | - | 4,074 | - | - | - | 1,954 | - | - | - | 1,151 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 42.1% | -97,875 | -169,085 | -150,155 | -177,620 | -140,744 | -154,417 | -107,024 | -111,560 | -112,499 | -168,625 | -128,688 | -153,314 | 141,979 | -99,824 | -94,294 | -108,349 | -82,071 | -53,597 | -39,907 | -35,560 | -44,478 |
Share Based Compensation | 21.2% | 26,219 | 21,625 | 29,278 | 28,823 | 24,241 | 23,541 | 22,530 | 20,773 | 19,312 | 17,194 | 17,722 | 16,439 | 12,494 | 12,099 | 11,489 | 9,294 | 7,107 | 5,295 | 4,183 | 4,559 | 1,828 |
Cashflow From Investing | 108.5% | 4.00 | -47.00 | -372 | -259 | 124,129 | 124,784 | 82,929 | -271,949 | 84,980 | 179,649 | 129,752 | -146,765 | -91.00 | 198,763 | -287,807 | -227,854 | -155 | -471 | -192 | -875 | - |
Cashflow From Financing | -168.1% | -3,913 | 5,746 | 1,560 | 391,106 | -15,946 | 9,636 | -4,735 | 376,704 | 383,958 | 2,120 | 4,526 | 1,632 | 6,317 | 926 | 281,668 | 403,267 | 209 | 198,950 | 40,964 | 148,418 | 115 |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenue: | |||
Total product revenue, net | $ 396,591 | $ 75,422 | $ 66,563 |
Operating expenses: | |||
Cost of sales | 58,510 | 5,636 | 200 |
Research and development | 354,387 | 387,236 | 345,869 |
Cost of research collaboration | 75,000 | ||
License expense | 5,000 | ||
General and administrative | 500,815 | 277,163 | 176,771 |
Total operating expenses: | 913,712 | 670,035 | 602,840 |
Net operating loss | (517,121) | (594,613) | (536,277) |
Loss on conversion of debt | (32,890) | (100,589) | |
Loss from remeasurement of development derivative liability | (97,675) | ||
Interest income | 20,933 | 8,914 | 418 |
Interest expense | (29,581) | (32,626) | (13,241) |
Other(expense)/ income, net | (727) | (288) | 1,362 |
Net loss before taxes | (526,496) | (651,503) | (746,002) |
Income tax expense | 2,132 | 669 | 352 |
Net loss | (528,628) | (652,172) | (746,354) |
Other comprehensive income/(loss): | |||
Unrealized (loss)/gain on marketable securities | (1) | 9 | |
Unrealized (loss)/gain on pension plans | (2,618) | 1,646 | |
Foreign currency (loss) | (49) | (430) | (1,982) |
Total other comprehensive income/(loss) | (2,667) | 1,215 | (1,973) |
Comprehensive loss, net of tax | $ (531,295) | $ (650,957) | $ (748,327) |
Net loss per common share, basic | $ (4.45) | $ (6.15) | $ (8.84) |
Net loss per common share, diluted | $ (4.45) | $ (6.15) | $ (8.84) |
Weighted-average number of common shares used in net loss per common share, basic | 118,678 | 106,114 | 84,421 |
Weighted-average number of common shares used in net loss per common share, diluted | 118,678 | 106,114 | 84,421 |
Product revenue, net [Member] | |||
Revenue: | |||
Total product revenue, net | $ 366,281 | $ 65,092 | $ 15,147 |
Licensing and other revenue [Member] | |||
Revenue: | |||
Total product revenue, net | $ 30,310 | $ 10,330 | $ 51,416 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 351,185 | $ 551,801 |
Accounts receivable | 206,442 | 7,727 |
Inventory | 146,362 | 85,714 |
Prepaid assets | 38,820 | 36,350 |
Restricted cash | 1,114 | 1,273 |
Other current assets | 22,408 | 36,658 |
Total current assets | 766,331 | 719,523 |
Non-current assets: | ||
Right-of-use assets | 16,745 | 18,747 |
Property and equipment, net | 4,345 | 6,148 |
Other assets | 1,309 | 15,799 |
Total assets | 788,730 | 760,217 |
Current liabilities: | ||
Accounts payable | 37,516 | 37,342 |
Accrued expenses | 127,806 | 95,139 |
Current portion of development liability | 75,830 | 29,504 |
Current portion of right-of-use liabilities | 6,441 | 5,625 |
Total current liabilities | 247,593 | 167,610 |
Long-term liabilities: | ||
Long-term development liability | 239,817 | 315,647 |
Convertible senior notes | 93,033 | 92,736 |
Right-of-use liabilities | 11,454 | 14,352 |
Other liabilities | 2,312 | |
Total liabilities | 594,209 | 590,345 |
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value; 10,000 shares authorized and zero shares issued and outstanding at December 31, 2023 and 2022 | 0 | 0 |
Common stock, $0.0001 par value; 200,000 shares authorized at December 31, 2023 and 2022; 119,556 and 110,772 shares issued and outstanding at December 31, 2023 and 2022, respectively | 12 | 11 |
Additional paid-in capital | 3,035,539 | 2,479,596 |
Accumulated other comprehensive loss | (3,542) | (875) |
Accumulated deficit | (2,837,488) | (2,308,860) |
Total stockholders’ equity | 194,521 | 169,872 |
Total liabilities and stockholders’ equity | $ 788,730 | $ 760,217 |